Download presentation
Presentation is loading. Please wait.
Published byAmbrose Davis Modified over 9 years ago
1
Lookback study for transfusion- related HBV infection in Japan Tokyo Metropolitan Red Cross Blood Center Masahiro Satake
2
Aliquots from all donations have been stored since 1997. When necessary, each aliquot was investigated using individual donation-NAT (ID-NAT). Subjects for the study : converters for HBs-Ag, HBc-Ab, HCV-Ab, HIV-Ab, screening NAT for HBV, HCV or HIV during April 1999 and February 2005 Lookback study in Japan
3
ID-NAT results in repository tubes from seroconverted or NAT-converted donors No. of ID-NAT performed No. of positive tubes Positivity rate (%) HBV20,0332611.30 HCV4,37120.05 HIV1,67310.06 total 26,0772641.01 (‘99 April ~ ’05 February)
4
No. of HBV ID-NAT positive but pool-NAT negative donors estimated by lookback study Conversion / year ID-NAT positive No. of ID-NAT positive donors HBV-pool NAT 803.75%3.0 HB s -Ag 124 3.7 % 4.6 HB c -Ab 32691.0%32.6 total3473 1.16 % 40.2 These donations do not directly relate to infectivity.
5
The infectivity of HBV-ID-NAT positive components No. of ID-NAT positive donation 267 No. of components released 321 transfused ・・・・・・・・・・・ discarded ・・・・・・・・・・・ unknown ・・・・・・・・・・・ Outcome of transfused patients ( 191 reports available ) HBs-Ag conversion HBV-DNA conversion HBs-Ab conversion positive, but no information before transfusion 7 markers not changed dead discharged etc. 293 16 12 6 2 3 60 99 14
6
HBV infected Undetermined No change others 11 7 60 115 Infectious risk when transfused with ID-NAT positive blood 11 / 78 ~ 18 / 78 The infectivity of HBV-ID NAT-positive components 6 ~ 10 HBV infections per year
7
Infectivity of HBV ID-NAT positive components ComponentInfected No change totalinfectivity Window period (HBcAb -) 10213132% (10/31) Chronic carrier (HBcAb +) 139402.5% (1/40) Infectivity of W.P. component is 13 times as high as that from chronic carrier.
8
Implicated components component From window period From chronic carrier RBC 5 / 10 (50%) 0 / 19 FFP 3 / 10 (30%) 1 / 18 (6%) Platelet 2 / 4 (50%) 0 / 1
9
Established cases for HBV infection Disorders of patients hematologic malignancy2 gastric cancer2 dissecting aortic aneurysm 1 shock due to multiple trauma1 rheumatoid arthritis1 unknown4
10
ID-NAT in repository tubes --- voluntarily reported HBV cases ---
11
The risk of HBV infection under current screening algorism including 50p-NAT system SourcesHBV-infection Lookback investigation 6 ~ 10 Voluntary report of infection 5 total 1 1 ~1 5 cases / year
12
Lookback study for HCV and HIV No. of ID-NAT performed No. of positive tubes HCV 4,371 2 (1 donation before NAT implementation) HIV 1,673 1 (Established infected case) Seroconversion possibly due to nonspecific reaction was also subjected to lookback study.
13
Estimates for the Occurrence of Transfusion- Transmitted Viral Diseases in Japan HBV HBV+ donation detectable only by ID-NAT : 1 / 150,000 11 ~ 15 infection cases per year ( 1 infection / 3.6 ~ 5.4 x 10 5 components ) HCV ( difficult to estimate ) HCV+ donation detectable only by ID-NAT : 1 / 24 million ( 1 component / 4 years ) HIV ( difficult to estimate ) HIV+ donation detectable only by ID-NAT : 1 / 12 million ( 1 component / 2 years )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.